CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test
Introduction
The CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test is a specialized diagnostic tool designed to identify mutations in the CFAP298 gene, which is associated with primary ciliary dyskinesia (PCD). PCD is a genetic condition that affects the movement of cilia, leading to respiratory and fertility issues. Early diagnosis is crucial for effective management and treatment of the symptoms associated with this disorder.
What the Test Measures
This genetic test detects specific mutations in the CFAP298 gene. By analyzing the DNA, the test can confirm whether an individual has PCD and provide insights into the severity of the condition.
Who Should Consider This Test
Individuals experiencing chronic respiratory problems, recurrent infections, or those with a family history of PCD should consider this test. Symptoms may include:
- Chronic cough
- Frequent lung infections
- Sinusitis
- Infertility in males
Benefits of Taking the Test
Taking the CFAP298 Gene test provides multiple benefits, including:
- Accurate diagnosis of primary ciliary dyskinesia.
- Guidance for effective treatment plans.
- Informed family planning options.
- Access to specialized medical care and support.
Understanding Your Results
Results from the CFAP298 Gene test typically take 3 to 4 weeks. A genetic counselor will provide guidance on interpreting the results, helping you understand the implications for your health and any necessary next steps.
Test Pricing
| Price Type | Amount (KSh) |
|---|---|
| Discount Price | 40,000 |
| Regular Price | 56,000 |
Book Your Test Today
We have branches across Kenya, making it easy for you to access our services. To book the CFAP298 Gene Primary Ciliary Dyskinesia Type 26 NGS Genetic DNA Test, please call or WhatsApp us at +254711564616. Don’t wait—take the first step towards better health today!
